Presentation and management of choriocarcinoma after nonmolar pregnancy

British Journal of Obstetrics and Gynaecology
J A TidyP Rowden

Abstract

To ascertain the mode of presentation and treatment outcome for women with choriocarcinoma after a nonmolar pregnancy. Retrospective analysis of case records between 1985 and 1994. A referral centre for trophoblastic disease. One hundred women with choriocarcinoma: 62 after a live birth, six after a live birth preceded by a molar pregnancy and 32 after a nonmolar abortion. Choriocarcinoma after nonmolar pregnancies represent 17% of the total gestational trophoblastic tumours requiring treatment. Vaginal bleeding was the commonest symptom in all groups, but symptoms from metastatic disease were important in the group presenting after a live birth. Metastatic disease was present in 31% of cases after live birth and 43% post-abortion. The median interval between the antecedent pregnancy and choriocarcinoma was five and six months, respectively. High risk multi-agent chemotherapy was required in 82% and 60% of cases, respectively. The mortality rate was significantly higher after a live birth than a nonmolar abortion (21% vs 6%). Treatment of choriocarcinoma after a live birth is associated with an unacceptably high mortality rate. Vaginal bleeding is an important early symptom and a pregnancy test should be performed if it persist...Continue Reading

References

Jul 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G J RustinK D Bagshawe
Jul 1, 1989·British Journal of Obstetrics and Gynaecology·K D BagshaweG J Rustin
Jan 1, 1995·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·R.A. FisherE.S. Newlands

❮ Previous
Next ❯

Citations

Mar 17, 2009·Archives of Gynecology and Obstetrics·Vassilios LiberisNikoleta Koutlaki
Nov 4, 1998·Lancet·P SavageM J Seckl
Nov 15, 2003·Best Practice & Research. Clinical Obstetrics & Gynaecology·John T Soper
Jul 30, 2002·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·O M McNallyM A Quinn
Sep 16, 2003·Clinical Obstetrics and Gynecology·John T Soper
May 29, 2009·The Journal of Perinatal & Neonatal Nursing·Susan Drummond, Elizabeth Fritz
Jun 28, 2013·Obstetrical & Gynecological Survey·Kemi M Doll, John T Soper
Nov 21, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Y MaX Y Yang
Jan 5, 2011·World Journal of Surgical Oncology·Nikolaos ThomakosAris Antsaklis
Mar 6, 2010·Case Reports in Medicine·Anna-Karina Aaris HenningsenJens Svare
Sep 10, 2014·Case Reports in Pediatrics·Timothy Brooks, Laura Nolting
Apr 9, 2008·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·A Mukhopadhyay, M Mammo
Feb 1, 2011·Clinics in Chest Medicine·N FreymondJ F Cordier
Jan 15, 2010·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Cindy OoiLois Eva
Mar 15, 2006·European Journal of Obstetrics, Gynecology, and Reproductive Biology·L-C HornJ Einenkel
Mar 30, 2016·Gynecologic Oncology·L JiaoM J Seckl
Jan 1, 2012·Gynecologic Oncology Case Reports·Joelle GetrajdmanLinus Chuang
Mar 3, 2015·Gynécologie, obstétrique & fertilité·L EminS Girard
Jan 13, 2017·Obstetrics and Gynecology·Alyssa LarishCarrie Langstraat
Jun 18, 2002·BJOG : an International Journal of Obstetrics and Gynaecology·Juhani VartiainenUlf-Håkan Stenman
Jul 17, 2004·Acta Obstetricia Et Gynecologica Scandinavica·Sonia AnderssonFolke Flam
Apr 23, 2005·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·N J Sebire
Jul 4, 2006·Obstetrics and Gynecology·John T Soper
Jun 28, 2000·The Australian & New Zealand Journal of Obstetrics & Gynaecology·M SoodR Sen
Sep 26, 2000·BJOG : an International Journal of Obstetrics and Gynaecology·A NozueT Kubo
Apr 3, 1999·British Journal of Cancer·L S DobsonB W Hancock
Jan 1, 1997·British Journal of Obstetrics and Gynaecology·R A CrawfordK D Bagshawe
Mar 9, 2020·BJOG : an International Journal of Obstetrics and Gynaecology·P SavageM J Seckl
Dec 19, 2019·American Journal of Physiology. Cell Physiology·Zhilong ChenQing Yang
Oct 1, 2020·BJOG : an International Journal of Obstetrics and Gynaecology
Dec 16, 1998·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·S M JacquesA Munkarah
Jan 9, 2021·Obstetrics and Gynecology·John T Soper
Dec 29, 2020·Obstetrical & Gynecological Survey·Ioannis TsakiridisThemistoklis Dagklis
May 27, 2021·Bioengineered·Ying ShanJianglong Zhu
Nov 1, 2020·Best Practice & Research. Clinical Obstetrics & Gynaecology·Siew-Fei Ngu, Hextan Y S Ngan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Obstetrics and Gynecology
D L OliveJ I Brewer
The Australian & New Zealand Journal of Obstetrics & Gynaecology
W S Tow
Gynecologic Oncology
R S BerkowitzM Bernstein
© 2021 Meta ULC. All rights reserved